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Abstract	
Objective: The objectives of this study are to determine what is the minimal volume required to perform an 
effective fluid challenge (FC) and to investigate how different doses of intravenous fluids in a FC affect the 
changes in cardiac output and the proportion of responders and non-responders. 
Design: quasi-randomised controlled trial. 
Setting: Cardiothoracic intensive care unit, tertiary university hospital 
Patients: 80 Post-cardiac surgery patients. 
Intervention: intravenous infusion of 1, 2, 3 or 4 mL/Kg (body weight) of crystalloid over 5 minutes.  
Measurements: Mean systemic filling pressure measured using the transient stop-flow arm arterial-venous 
equilibrium pressure (Pmsf-arm), arterial and central venous pressure (CVP), cardiac output (CO; LiDCOplus, 
LiDCO, Cambridge, UK) and heart rate. 
Results: The groups were well matched with respect to demographic and baseline physiological variables. 
The proportion of responders increased from 20% in the group of 1mL/kg to 65% in the group of 4 mL/kg (p = 
0.04). The predicted minimal volume required for a FC was between 321 to 509 mL. Only 4 mL/Kg increase 
Pmsf-arm beyond the limits of precision and was significantly associated with a positive response (OR 7.73, 
95% CI 1.78 to 31.04).  
Conclusion: The doses of fluids used for a FC modify the proportions of responders in postoperative 
patients. A dose of 4 ml/Kg increases Pmsf-arm and reliably detects responders and non-responders. 
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Introduction	
One of the commonest interventions performed in critical care is a fluid challenge (FC). A FC is the 
administration of a “small” amount of intravenous (IV) fluids, in order to assess the cardiac response to an 
increase in intravascular volume 1,2. Despite the simplicity of this test, it is unclear how much volume should be 
used to perform a FC. Volumes from 100 mL up to 3 litres have been reported in the literature 3 and similar 
results are observed in clinical practice as reported recently in a large multicentre study about the FC technique 
with a median volume of 500 mL (500 – 999 mL)4.  
The mean systemic filling pressure (Pmsf) is a quantitative measure of the intravascular volume. It is the 
pressure in the cardiovascular system when there is no blood flow, and it is defined by the relationship between 
intravascular stress volume and mean vascular capacitance. Guyton observed that acute expansion of 
intravascular volume increases venous return insofar as the increase in volume increases Pmsf 5. As under 
steady conditions, venous return equals CO, an effective FC should be able to increase the Pmsf in order to 
challenge the cardiac response, otherwise, the volume given may have no haemodynamic effect and it would be 
possible that a number of non-responders might be actually non-challenged. 
Cecconi et al6 reported that a FC of 250 ml increased the Pmsf analogue by 3.1 ± 1.9 mmHg. Recently, a 
study 7 about the precision of the measurement of the Pmsf-arm reported a least significant change (LSC) of 
14 % of baseline value for a single measurement, which is the minimal change that should be observed in order 
to believe that a real change occurs beyond the limits of precision. We hypothesise that the volume of fluids 
may affect not only the change in Pmsf but also the change in CO and the proportion of responders to a FC. 
Thus, the objectives of the present study are, first, to determine what is the minimal volume of intravenous 
fluids required to increase the Pmsf-arm by the LSC to perform an effective FC and, second, to determine how 
different doses of fluids in a FC affect the changes in CO and the proportion of responders.   
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Methods	
This study was approved by the Camden & Islington Research Ethic Committee (13/LO/1307, December 
2013). Written informed consent was obtained from all patients.  
Study	design	
This is a quasi-randomised 8,9, single–blinded, controlled study with an allocation ratio of 1:1. The different 
arms consisted of doses of 1, 2, 3 and 4 ml/kg (actual body weight) of Compound Sodium Lactate (Hartmann’s 
Solution, Baxter, Thetford, UK) as a FC infused over 5 minutes manually using a syringe of 60 mL and a timer 
in the multi-parameter monitor. Patients were approached when admitted to hospital before cardiac surgery. The 
first 20 patients were allocated to receive 1mL/kg (total body weight), the following 20 to 2 mL/Kg and so on. 
Pmsf-arm, mean arterial pressure (MAP), CO, SV, heart rate (HR) and CVP were recorded at baseline and after 
the FC. After the second measurement, the dose of fluids was completed according to the clinical prescription. 
Clinical indication for a FC was according to the standard clinical post-operative protocol 10 (Supplemental 
Digital Content (SDC) Figure 1). 
Participants	
Patients admitted to cardiothoracic intensive care unit (ICU) following cardiac surgery were prospectively 
enrolled. Patients with occlusive peripheral vascular disease, post-operative valve regurgitation, presence of an 
intra-aortic balloon pump, pregnancy, body weight below 50 kg, absence of radial arterial catheter, evidence or 
strong suspicious of active bleeding or sepsis and patients requiring fluid resuscitation or changes in vasoactive 
therapy were excluded from the study. All patients were studied during the initial period in the ICU, once they 
achieved a hemodynamic and respiratory steady state, defined by changes no greater than 10 % in heart rate, 
respiratory rate, CO, stroke volume, arterial pressure and arterial saturation of oxygen for at least ten minutes.  
Measurements	
Invasive arterial pressure and CVP were used for the study. Pressure transducers were referenced to the 
intersection of fifth intercostal space and anterior axillar line and connected to the multi-parameter monitor 
(IntelliVue MX800, Philips Healthcare, Best, Netherlands) with patients lying fully supine in bed. Pmsf-arm 
was measured using the transient stop-flow arterial venous equilibrium method 11 by stopping the blood flow in 
the arm using a pneumatic tourniquet (AT4 pneumatic tourniquet, AneticAid, Leeds, UK) to pressures 50-60 
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mmHg above systolic pressure and held for 60 seconds. Pmsf-arm is defined as the arterial pressure at 60 
seconds of cuff-inflation 7. CO was monitored with a non-calibrated LiDCOplus monitor (version 4.02.92) or 
with a pulmonary artery catheter (Edwards Lifesciences, Irvine, USA). Responders are defined as an increase in 
CO equal or greater than 10% from baseline. 
Statistical	analysis	
Sample size calculation is described in detail in the SDC. Descriptive statistics and graphics were used to 
understand the data structure and the variables nature. Continuous variables are summarized by their means, 
medians, standard deviations and/or inter-quartiles. Categorical or binary variables are summarized in terms of 
proportions stratified by patients’ groups.  
Differences	between	dose	groups	
The analyses consist of a series of regression models for differences in changes of haemodynamics (i.e. ΔPmsf-
arm) on dose of fluids (1, 2, 3, and 4 ml/kg), CO response groups (responders and non-responders) and adjusted 
for the haemodynamic of interest at baseline (i.e. Pmsf-arm baseline). The predicted means of the changes in 
each group adjusted for the mean values of the corresponding baseline are reported after fitting the most 
parsimonious model. Proportions are compared with a chi-square test.  
Determination	of	minimal	volume	
To determine the minimal volume required to increase Pmsf-arm by 14%, step-wise multiple linear regression 
was used with change of Pmsf-arm as dependent variable. The set of independent predictors explored included 
Pmsf-arm baseline, volume (mL), weight (Kg), concomitant use of vasodilators (Morphine, Alfentanil, 
Milrinone and/or Nitroglycerin), Diabetes Mellitus status, use of extracorporeal circulation (pump) intra-
operatively, concomitant use of vasoconstrictors (Dopamine, Noradrenaline, Adrenaline), baseline arterial 
pressure (MAP) and temperature. To estimate the minimal volume, the model was run to predict the values of 
∆Pmsf-arm for all the baseline values, and we choose the volume values (mL) for which the outcome would 
achieve a 14 % increase in the lower bound of the 95% CI. The presence of missing values have been assessed 
(cardiac echocardiographic parameters) and the data have been analysed using multiple imputation techniques 
under missing at random assumption 12. Fluid responsiveness was also considered as a binary outcome 
(responders vs non-responder). A logistic regression was employed to estimate the odds ratio (OR) of 
responders vs. non-responders by dose of crystalloids infused. Hosmer Lemeshow statistic tested the goodness 
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of fit of the model. P-values of less than 0.05 were considered statistically significant. Statistical analysis was 
conducted using SPSS for Macintosh software (IBM, version 21.0.0) and STATA (StataCorp. 2013. Stata 
Statistical Software: Release 13. College Station, TX: StataCorp LP).   
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Results	
119 patients were screened between September 2014 and January 2015. Out of those, 39 did not satisfy the 
eligibility criteria (SDC – Figure 2). Baseline demographic and clinical characteristics of participants by group 
are presented in the SDC – Table 1. Except for heart rate, there were not significant differences between groups 
at baseline. 
33 patients (41.3 %) were responders to the FC. The proportion of responders is significantly different 
across the four groups (χ2 (3) 8.82, p = 0.038; Figure 1). This difference is attributable to responders of group 1 
(20%) and group 4 (65%). Proportions of responders between groups 1, 2 and 3 mL/kg were not significantly 
different.  
Descriptive statistics of changes in haemodynamics by dose of crystalloids and CO response are presented 
in Table 1 and estimated differences by dose of crystalloids and CO response adjusted by baseline values are 
reported in Table 2. Predicted changes of haemodynamics adjusted by baseline values are presented in SDC – 
Table 2. ΔPmsf-arm was significantly greater with 2, 3 and 4 ml/kg compared to 1 mL/kg (p = 0.007, 0.01 and < 
0.001 respectively, Figure 2). The changes on other haemodynamic parameter are explained in detail in the SDC. 
The regression model of ∆Pmsf-arm (%) revealed as significant predictors Pmsf-arm at baseline and the 
absolute volume (mL) infused. There is not enough evidence to support a strong effect of the concomitant use of 
vasodilators on ∆Pmsf-arm (%), however, it was considered clinically relevant and was maintained into the 
model (Table 3). Weight was neither a significant predictor (B -0.01 (95% CI -0.19, 0.16), p =0.88) nor the 
interaction with volume (mL) (p = 0.42). An increase of 1 mL of crystalloids increases the ∆Pmsf-arm by 0.05% 
holding the Pmsf-arm at baseline and the use of vasodilators constant. The estimated volume required to achieve 
a change in Pmsf-arm of at least 14% in the lower limit of the 95% confidence interval, adjusted by the Pmsf-
arm at baseline is between 321 to 393 mL without vasodilators and between 446 to 509 mL in those patients 
where vasodilators were being used (SDC – Table 3). 
There is only some marginal evidence (p = 0.07) to support some differences between patients with severe 
diastolic dysfunction and those with normal diastolic function of left ventricle (SDC – Table 4). 
In the logistic regression model, only the dose of 4 mL/Kg was significantly associated with the probability 
of a positive response to the FC compared to 1 mL/Kg. (O.R. 7.43, 95% C.I. 1.78 to 31.04; SDC – Table 5).  
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Discussion	
The findings of this study demonstrate the importance of the volume used for a FC on the effectiveness of 
this cardiovascular test. Small volumes seem to be less likely to increase the Pmsf-arm and this affects the 
ability to identify responders in terms of CO: up to 45% of responders may possibly be misclassified as non-
responders. The change in CO is strongly affected by the dose used and very little affected by the systolic or 
diastolic function at baseline. The Pmsf-arm at baseline and the volume infused are the major determinants of 
the change in Pmsf: volumes between 320 to 510 mL, which are fairly equivalent to 4 mL/Kg, seem to be 
sufficient for an effective FC. When an effective FC is performed, MAP increases along with the CO, and CVP 
increases in both responders and non-responders.  
The effect of blood volume on Pmsf was already demonstrated by Guyton’s experiments 5. The ΔPmsf 
depends on the change of stressed volume and the capacitance of the vascular system 13, which in turns depends 
on several factors such as the sympathetic tone, hypercapnea, hypoxia and aortic and cardiopulmonary 
chemoreceptors 14. The Pmsf values reported in this study are similar to previous studies in similar populations 
6,7,11, and the baseline values are very similar in the four groups, which reassure that the haemodynamic effect of 
the intravascular volume was fairly similar on the four groups. Noradrenaline can increase Pmsf and reduce 
vascular capacitance 15,16 but in our study the infusion of vasoconstrictors did not show a significant effect on 
∆Pmsf-arm. Conversely, the infusion of vasodilators, although not reaching statistical significance, has a clinical 
impact on the dose required for a fluid challenge, which is explain by the increase in unstressed volume. The 
volume infused and the Pmsf-arm at baseline explains only 28% of the total variability of the change in Pmsf-
arm, which point out the complexity of the regulation of the vascular capacitance: in 24.7% of cases the Pmsf-
arm did not change (only in the group of 1 mL/Kg) after the FC. Capacitance vessels tone, interstitial pressure 
and trans-capillary fluid flow are some of the relevant factors that could possibly explain the great variability 
associated to the change of Pmsf. 
Pmsf at baseline is a significant predictor, inversely related to the change of Pmsf-arm: for one mmHg of 
increase of Pmsf-arm at baseline, the ∆Pmsf-arm will decrease by 0.35 mmHg. This may suggest that there is a 
physiological upper limit for Pmsf regardless the volume given, so that part of the volume is redistributed 
between stressed and non-stressed compartments or distributed between the intravascular and extravascular 
space. 
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In some cases the CO increases despite an increase of Pmsf below the LSC. This can be explained by the 
gradient generated between the intravenous pressure and the mechanical force used to infuse the fluids into the 
venous system. Small volumes infused at a high rate may push enough blood into the right ventricle, emulating 
an increase in venous return and testing the preload reserve of the right heart. In addition, other factors 
associated with the cardiac sensitivity to the change in preload must be taken into consideration: our results 
suggest that severe diastolic dysfunction may reduce this sensitivity, but these results should be taken with 
caution as this study was not specifically design to answer this question. The results of our analysis of the 
changes of CO according to the LV or RV function only highlights that fact that the main factor that explain the 
differences is the dose of crystalloids used.  
The changes observed in CVP suggest that this variable cannot be used as a safety limit, as there is no 
evidence to support the assertion that changes on CVP differ between responders and non-responders. This is in 
agreement with a recent study that showed that the overall impact of a fluid challenge on the CVP is greater in 
non-responders, but not the change at any particular time point after the fluid infusion17. However, CVP could 
be possibly used as indicator of effectiveness of the test: it only increases in the group of 4 mL/Kg, where the 
changes in CO and Pmsf were clear. The increase of CVP in responders can be explained by a physiological 
increase in right atrial pressure and right ventricle (RV) end-diastolic pressure in response to an increase in 
venous return that transitory overcomes the RV capacity. 
Our results may bring into question the negative predictive value of small volumes to reliably assess fluid 
responsiveness. Muller et al 18 proposed a mini-FC using an infusion of 100 ml of colloids over 1 minute in 
patients with acute cardiovascular failure. The response was assessed measuring the variation of sub-aortic 
variation time index (VTI) using Doppler echocardiography after 100 ml and then after the infusion of 400 mL 
of colloids over 14 minutes. The authors proposed a dVTI cut-off of 10 %, which had a sensitivity of 95 % and 
specificity of 78% with a negative predictive value of 93 %. In contrast with our study, Muller et al. chose 
colloids, which are known to increase CO more than crystalloids 19,20, the VTI may also be more sensitive and 
less dependent on accuracy of arterial catheters and, much more importantly, Muller and colleagues studied 
patients with acute circulatory failure where all the normal cardiac reflexes may not work properly. Guinot and 
colleagues 21 reported a similar study using crystalloids and measuring the change in SV by thoracic impedance 
cardiography. A dSV of 7% after 100 mL of crystalloids showed a sensitivity of 89 %, specificity of 89 % with 
a negative predictive value of 93%. Another important difference with our study is the method use to assess 
fluid responsiveness, as we use continuous CO based on pulse-power analysis. Mallat et al 22 carried out a 
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similar study in 49 fully sedated patients using the PiCCO device (PiCCO, Pulsion Medical System, Munich) to 
measure continuous cardiac index (CCI). The area under the receiver operating characteristic curves (AUC) for 
the dCCI after 100 mL of colloid infusion over 1 minute was 0.78 with a large grey zone that included 67 % of 
the subjects. For a cut-off value of 5.2% for dCCI after 100 mL, sensitivity was 77% and specificity 74%. 
Limitations		
There are some limitations in this study that need to be acknowledged. First, there is a different rate of fluid 
infusion, which probably has an important effect on the changes of haemodynamics. A minimum period of 5 
minutes was required between 2 inflations of the tourniquet to measure Pmsf-arm without triggering local 
ischaemic mediators that can affect the precision of the technique 7. Thus, to maintain a constant rate, it would 
have been necessary to administer the FC over 25 minutes or longer (15 mL/min) in the 4 mL/Kg group, which 
was considered too long for a FC. Second, arm occlusion method is a non-invasive method to measure Pmsf-
arm in patients with intact circulation, but its accuracy remains uncertain giving the difficulties to measure the 
real Pmsf. Pmsf-arm was compared with other minimally invasive methods showing good correlation with other 
values11, but none of those methods can be considered as a gold-standard to measure Pmsf, and all of them have 
limitations and potential pitfalls. In a dog model the Pmsf is between 7 and 12 mmHg while the CVP is between 
2-3 mmHg23. It is likely that Pmsf in normal humans is similar to dogs. The baseline Pmsf in this study was 23.6 
mmHg. This higher Pmsf may partly be explained by the higher CVP as the Pmsf must be higher than the CVP 
to ensure venous return. Nevertheless, the precision of the Pmsf-arm, which is the relevant concept in this study, 
was studied and reported in a previous study7. Third, we used a non-calibrated LiDCOplus monitor, which 
clearly affects the accuracy of CO measurements. However, this device incorporates two independent systems: 
the LiDCO™ lithium dilution technique and the PulseCO™ pulse power algorithm, which can reliably track 
changes of CO 24. Fourth, we selected a fairly homogeneous sample of post-operative cardiac surgery patients 
that were in a stable haemodynamic state. This was necessary to obtain good quality data and to avoid further 
variability in the results as cardiovascular compliance can vary significantly in other sub-populations of 
critically ill patients. This may bias our sample to a relatively healthy subpopulation of critically ill patients. 
Therefore, our results may not be extrapolated to other subgroups such as septic or trauma patients, where the 
unstressed volume might be substantially reduced, and the compliance substantially modified. Those patients 
may require a greater dose for an effective test. Fifth, patients were allocated to each group using a quasi-
randomisation approach, as defined by the Cochrane handbook9. This method of allocation increases the risk of 
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systematic errors related to the environment that may interfere with the measurement process and selection bias. 
For that reason a comparison of the baseline values and demographic characteristics was conducted, and it 
demonstrates a reasonable equality between groups. Nevertheless, a strict randomisation would have added 
further robustness to this study. 
Conclusion	
The dose of fluids used for a FC can modify the proportions of responders in a cohort of postoperative 
patients. A dose of 4 ml/Kg increases Pmsf-arm beyond the limits of precision and reliably detects responders 
and non-responders.  
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Figure	Legends	
Fig 1 Proportion of responders and non-responders by dose of crystalloids used for a fluid challenge. 
Proportions are compared across different doses of crystalloids with a chi-square statistic. 
 
 
Fig 2 Predicted mean of changes of Pmsf-arm (%) adjusted by the mean baseline value of Pmsf-arm, by dose of 
crystalloids used for a fluid challenge. Error bars represent 95% confidence interval. Horizontal line represents 
the threshold for the least significant change of Pmsf-arm. 
 
 
